Author:
Anolik Jennifer,Sanz Iñaki,Looney R. John
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Godfrey T, Khamashta M, Hughes G: Therapeutic advances in systemic lupus erythematosus. Curr Opin Rheumatol 1998, 10:435–441.
2. Weisman M, Blustein H, Berner C: Reduction in circulating dsDNA antibody titer after adminstration of LJP 394. J Rheumatol 1997, 24:314–318.
3. Davis J, Tortoritis M, Rosenberg J: Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus. J Rheumatol 2001, 28:95–101.
4. Shlomchik M, Craft JE, Mamula MJ: From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001, 1:147–153. A thorough review of abnormalities in the T and B cell compartments in lupus-prone mice is provided in the context of a model to explain the development and maintenance of autoimmunity in SLE. Emphasis is placed on self-reinforcing interactions of T and B cells that lead to the loss of self-tolerance to nuclear autoantigens. The hypothesis is put forth that simultaneous T and B cell directed therapies of SLE should be synergistic.
5. Lipsky PE: Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001, 2:764–766. An excellent review of B cell abnormalities in SLE, with a discussion of the multiple roles B cells play in the normal immune response and potential derangements in autoimmunity.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献